Skip to main content

Search GE Press Releases

Filter press releases

Start date
End date
Business
Showing 1 - 10 of 84 results within GE Newsroom

GE Healthcare Announces European Union Approval of VIZAMYL™ (Flutemetamol (18F) solution for injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer's Disease

September 01, 2014
PET Imaging Agent Receives Marketing Authorisation from the European Commission Chalfont St. Giles, UK -- 1st September, 2014 -- GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F)…

GE Healthcare Life Sciences to Create New US Headquarters in Massachusetts

August 20, 2014
When fully operational, new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts Long-term investment places new US business headquarters at…

GE Healthcare: New Dementia Research Reveals Overwhelming Demand for "The Value of Knowing"

August 19, 2014
3 out of 4 people globally would want to know what neurological disorder they have even if there was no cure; women outnumber men in desire to know 94% say diagnosis should be funded by either…

New Studies Presented at Alzheimer's Association International Conference Demonstrate Diagnostic Value of GE Healthcare's [18F]Flutemetamol

July 16, 2014
Use of [18F]flutemetamol PET scans can help predict progression from amnestic mild cognitive impairment to probable Alzheimer's Disease Second study sows use of [18F]flutemetamol leads to changes…

CHMP Recommends EU Approval of VIZAMYL™ (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque

June 30, 2014
-- PET Imaging Agent Receives Positive Opinion -- Chalfont St. Giles, UK -- June 30, 2014 -- GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's…

Personalized Care from Disease Detection through Treatment Assessment Enabled with GE Healthcare's Discovery IQ

June 09, 2014
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality…

GE Healthcare Announces FDA Approval to Supply Technetium 99m Generators

May 30, 2014
Princeton, NJ -- May 30, 2014 -- Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for…

Economic Model Compares Iso-osmolar and Low-Osmolar Contrast Agents in Regard to Cost Associated With Contrast -Induced Acute Kidney Injury

May 29, 2014
Iso-Osmolar Contrast was More Cost-Effective than Low-Osmolar Contrast Princeton, NJ -- May 29, 2014 -- Results of GE Healthcare-supported economic modeling of a retrospective meta-analysis of…

Data From a Pooled Analysis Presented at American Academy of Neurology's 66th Annual Meeting Shows Diagnostic Effectiveness of DaTscanTM (Ioflupane I123 Injection)

April 29, 2014
Philadelphia, PA, April 29, 2014 -- Data from a pooled analysis of four clinical trials, presented today at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, showed that using…

GE Healthcare Announces First U.S. Markets For New Alzheimer's Diagnostic Tool for Detection of Beta Amyloid

April 29, 2014
Supporting Electronic Reader Training Program launched to train physicians to interpret images taken using PET imaging with Vizamyl™ Vizamyl to be commercially available in late 2Q 2014 Princeton,…